摘要
药耐药(MDR)是一种重要的各种因素限制下chemoor癌症放疗疗效。新的证据表明,MDR是一个受多种因素的调节的复杂过程,其中应激反应的分子是关键因素。AMP激活的蛋白激酶(AMPK)是一个一个主要的调节器来平衡能源供应,最终保护细胞通过协调多个代谢途径免受有害的压力,AMPK激活最近在耐药肿瘤细胞包括华宝作用和线粒体生物合成促进调解代谢重编程。此外,AMPK活性已被证明是调节难治性化疗的癌症干细胞的自我更新能力。此外,AMPK磷酸化介导自噬的诱导是至关重要的一个过程,可通过降解细胞敏感性的调制有效成分在压力条件下满足营养需求。同时,药物发现针对AMPK已被开发来验证在肿瘤防治中的AMPK的病理意义。虽然针对癌症治疗的AMPK调制冲突证据仍然存在,这可能是由于在AMPK亚型在特定组织中的差异,从目标的影响程度和药物管理和应力条件下的实验设置时间。本文将重点阐述AMPK介导的抗肿瘤治疗和讨论其潜在的治疗意义以及靶向药物的发展。
关键词: AMPK,自噬,肿瘤耐药,肿瘤干细胞,代谢。
图形摘要
Current Drug Targets
Title:Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
Volume: 17 Issue: 8
Author(s): Zhiyu Wang, Pengxi Liu, Qianjun Chen, Shigui Deng, Xiaoyan Liu, Honglin Situ, Shaowen Zhong, Swei Hann, Yi Lin
Affiliation:
关键词: AMPK,自噬,肿瘤耐药,肿瘤干细胞,代谢。
摘要: Mulitdrug resistance (MDR) is one of critical factorslimiting the efficacy of cancer chemoor radiotherapy. Emerging evidence has indicated that MDR is a complex process regulated by multiple factors, among which stress response molecules are considered as central players. AMP-activated protein kinase (AMPK) is a major regulator balancing energy supply and ultimately protects cells from harmful stresses via coordinating multiple metabolic pathways Notably, AMPK activation was recently shown to mediate the metabolism reprogramming in drug resistant cancer cells including promoting Warburg effects and mitochondrial biogenesis. Furthermore, AMPK activity has also been shown to regulate the self-renewal ability of cancer stem cells that are often refractory to chemotherapy. In addition, AMPK phosphorylation was critical in mediating autophagy induction, a process demonstrated to be effective in chemosensitivity modulation via degrading cellular components to satisfy nutrients requirement under stressful condition. Meanwhile, drug discovery targeting AMPK has been developed to validate the pathological significance of AMPK in cancer prevention and treatment. Although conflicting evidence focusing on the AMPK modulation for cancer treatment is still remained, this might be attributed to differences in AMPK isotypes in specific tissues, off-targets effects, the degree and duration of drug administration and experimental setting of stress conditions. This review will focus on AMPK mediated resistance to cancer therapy and discuss its potential therapeutic implication and targeting drug development.
Export Options
About this article
Cite this article as:
Zhiyu Wang, Pengxi Liu, Qianjun Chen, Shigui Deng, Xiaoyan Liu, Honglin Situ, Shaowen Zhong, Swei Hann, Yi Lin , Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy, Current Drug Targets 2016; 17 (8) . https://dx.doi.org/10.2174/1389450116666150316223655
DOI https://dx.doi.org/10.2174/1389450116666150316223655 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insects Antiviral and Anticancer Peptides: New Leads for the Future?
Protein & Peptide Letters From Bacteria to Antineoplastic: Epothilones A Successful History
Anti-Cancer Agents in Medicinal Chemistry Bacterial Colonization and Beta Defensins in the Female Genital Tract in HIV Infection
Current HIV Research Mesenchymal Cells in the Treatment of Spinal Cord Injury: Current & Future Perspectives
Current Stem Cell Research & Therapy Channel-Like Functions of the 18-kDa Translocator Protein (TSPO): Regulation of Apoptosis and Steroidogenesis as Part of the Host-Defense Response
Current Pharmaceutical Design Clinical Impact of the Detection of BRAF Mutations in Thyroid Pathology: Potential Usefulness as Diagnostic, Prognostic and Theragnostic Applications
Current Medicinal Chemistry Defining the Role of Integrin αvβ6 in Cancer
Current Drug Targets Mass Spectrometry Techniques: Principles and Practices for Quantitative Proteomics
Current Protein & Peptide Science In Vivo DNA Electrotransfer for Immunotherapy of Cancer and Neurodegenerative Diseases
Current Drug Metabolism The PAX8 / PPARγ Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents
Current Protein & Peptide Science Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Current Medicinal Chemistry Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Recent Patents on Anti-Cancer Drug Discovery Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy
Current Pharmaceutical Design Applications of Cellular Systems Biology in Breast Cancer Patient Stratification and Diagnostics
Combinatorial Chemistry & High Throughput Screening Molecular Mechanisms and Potential Treatment Targets for Ovarian Cancer by Analyzing Transcriptional Regulatory Network
Letters in Drug Design & Discovery Stem Cell Therapy for Spinal Cord Injury
Current Medicinal Chemistry DNA Methylation as a Target of Epigenetic Therapeutics in Cancer
Anti-Cancer Agents in Medicinal Chemistry Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued) Non Pregnant Human Uterus as Source of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy